The combining site of OKT3 was modeled,and Human Ig LS1 and ND were selected asacceptors of CDRs of OKT3 VL and VH to construct a reshaping antibody against CD3
The HTR Fuel Element R & D Program,set in 1987,aims to develop the manufacturetechnology of HTR fuel element and to produce the fuel element for the first core